The administration’s suggestion that psychotropic drugs pose a ‘threat’ to children has raised fears that a new presidential commission could recommend limiting medication access. Medscape Medical News
Tag: Neuropharmacology and Drugs
Seeing more in expansion microscopy
In biology, seeing can lead to understanding, and researchers in Edward Boyden’s lab at MIT’s McGovern Institute are committed to bringing life into sharper focus. With a pair of new methods, they are expanding the capabilities of expansion microscopy—a high-resolution imaging technique the group introduced in 2015—so researchers everywhere can see more when they look… Continue reading Seeing more in expansion microscopy
Are Your Patients Microdosing?
People you wouldn’t normally associate with drug use are self-treating by microdosing with psychedelics. Doctors need to be kept in the loop. Medscape Medical News
[ASAP] Discovery of a Novel Orally Active Ketamine Derivative with Dual Analgesic and Antidepressant Activities, Lacking Psychomimetic Effects
Total synthesis of ibogaine creates new opportunities for studying a psychoactive plant derivative
Researchers achieve total synthesis of ibogaine
Researchers have achieved total chemical synthesis of the psychoactive compound ibogaine and its analogs from pyridine. The discovery will make it easier to explore the therapeutic possibilities of ibogaine.
Study explores compound’s potential to enhance THC for pain treatment
Outcomes after further anesthetic procedures in patients with Perioperative Anaphylaxis at large tertiary care health system.
FDA OKs First-In-Class Nonopioid Pain Med Suzetrigine
Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective relief of acute pain without the risk of addiction. Medscape Medical News
Abuse potential and analgesic efficacy of intravenous hydromorphone bolus administration among hospitalized patients with cancer pain: A double‐blind, double dummy, randomized crossover trial
Abstract Background There is much concern that opioids administered as intravenous (iv) bolus for pain relief may inadvertently increase their risk for abuse. However, there is insufficient data to support this. The authors compared the abuse liability potential, analgesic efficacy, and adverse effect profile of fast (iv push) versus slow (iv piggyback) administration of iv… Continue reading Abuse potential and analgesic efficacy of intravenous hydromorphone bolus administration among hospitalized patients with cancer pain: A double‐blind, double dummy, randomized crossover trial